10 years of breakthroughs in organoid technology: from adult stem cell discovery to changing patients’ lives
WATCH NOW
In this webinar Rob Vries, CEO of HUB Organoids (Utrecht, The Netherlands) will review the history of organoid technology, from the initial organoid models derived from of adult stem cells of the intestine, to the most recent technological advances that have facilitated the development of reproducible and robust organoids. These developments have opened up these models to applications such as drug screening, personalized medicine and tissue regeneration.
This webinar was recorded September 6 2023
What will you learn?
- How the discovery of LGR5+ stem cells in the intestine led to the development of the first mini gut in a dish
- How stem-cell research has resulted in a variety of biobanks from both normal and disease tissue
- How the standardization of patient derived organoid cultures has enabled higher-throughput drug-screening studies
- How patients are currently being treated based on results from organoid testing
Who may this interest?
- Researchers interested in organoid technology
- Scientists developing new therapeutic agents, curious about the development and translatability of organoids
- Drug developers interested in the scale-up and high throughput potential of organoids for screening
Panelist
Robert Vries
CEO
HUB Organoids
Robert received his PhD in Biochemistry from the Leiden University Medical Center (The Netherlands) where he studied oncogenic cell transformation in the lab of Alex Jan van der Eb. He subsequently moved to Stanford University (CA, USA) to pursue his post-doctoral career on neural stem cells. Upon his return to The Netherlands, he joined the group of Hans Clevers at the Hubrecht Institute (Utrecht, The Netherlands) where he was involved in the development of the breakthrough “Organoid Technology” that allows the expansion of adult stem cells and the development of “mini-organs in a dish”. Rob is currently CEO of HUB, which was founded to further develop and refine the Organoid Technology.
In association with
